(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -106.34%-967.23K | -468.74K |
Payments to suppliers for goods and services | -106.34%-967.23K | ---468.74K |
Operating cash flow | -106.34%-967.23K | ---468.74K |
Investing cash flow | ||
Cash flow from continuing investing activities | -456.75%-930.42K | -167.12K |
Capital expenditure reported | -824.33%-851.46K | ---92.12K |
Net PPE purchase and sale | -5.29%-78.97K | ---75K |
Cash from discontinued investing activities | ||
Investing cash flow | -456.75%-930.42K | ---167.12K |
Financing cash flow | ||
Cash flow from continuing financing activities | -100.33%-20.52K | 6.16M |
Net common stock issuance | ---- | --6.16M |
Net other financing activities | ---20.52K | ---- |
Cash from discontinued financing activities | ||
Financing cash flow | -100.33%-20.52K | --6.16M |
Net cash flow | ||
Beginning cash position | 2,989.91%5.71M | --184.73K |
Current changes in cash | -134.73%-1.92M | --5.52M |
End cash Position | -33.61%3.79M | --5.71M |
Free cash from | -198.44%-1.9M | ---635.86K |
Accounting Standards | US-GAAP | US-GAAP |
No Data